Global Diabetic Ulcer Treatment Market Report and Forecast 2024-2032

Global Diabetic Ulcer Treatment Market Outlook

The global diabetic ulcer treatment market value was USD 5.52 billion in 2023, driven by the increasing prevalence of diabetes across the globe. The market size is anticipated to grow at a CAGR of 8.1% during the forecast period of 2024-2032 to achieve a value of USD 11.13 billion by 2032.

Rising Cases of Global Diabetes to Bolster the Market Growth of Diabetic Ulcer Treatment

The global market for diabetic ulcer treatment is majorly being driven by the increasing prevalence of diabetes. Diabetes is increasing at a startling rate around the world owing to adoption of sedentary lifestyles and unhealthy eating habits. As a result of this, ulcers caused by diabetes are thus becoming a significant factor contributing to the growth of the market. According to the American Diabetes Association (ADA), patients with diabetes are more prone to gum diseases resulting in a disruption in body’s blood sugar level and giving rise to mouth ulcers.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

The development of novel techniques to treat mouth ulcers aided by robust pharmaceutical research and development (R&D) is thereby stimulating the growth of the market. Furthermore, diabetic foot ulcers are becoming a leading cause of concern and, if left untreated, can lead to leg amputation and death in severe cases. These factors are therefore invigorating the growth of the market.

Diabetic Ulcer Treatment: Market Segmentation

Diabetic ulcers are a side effect of chronic diabetes and are usually found in the feet or mouth of the patient. Diabetic patients who depend on insulin are more likely to develop ulcers. The most common types of treatment include wound care dressings and active therapies.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

On the basis of treatment type, the market can be divided into:

• Wound Care Dressing
• Wound Care Devices
• Active Therapies

Wound care dressing can be further divided into antimicrobial dressings, film dressings, and alginate dressings, among others.

Wound care devices can be further segmented into negative pressure wound therapy, hyperbaric oxygen therapy, and ultrasound therapy, among others.

Active therapies can be sub-divided into skin grafts and substitutes, growth factors, and hemostatic agents and sealants, among others.

Based on grade, the market can be categorised into:

• Grade 1
• Grade 2
• Grade 3
• Grade 4
• Grade 5

The market, based on end-suer, can be segmented into:

• Hospital Inpatient Settings
• Hospital Outpatient Settings
• Community Health Centres
• Home Health Care
• Others

The EMR report looks into the regional markets of diabetic ulcer treatment like North America, Latin America, the Asia Pacific, Europe, and the Middle East and Africa.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Advancements in Medical Technology to Aid the Market Growth of Diabetic Ulcer Treatment

The rise in the global market for diabetic ulcer treatment can be associated with the rising demand for cost-effective treatment options for addressing the concerns of diabetic ulcers. The growing advancements in medical and pharmaceutical technology, such as the introduction of biomaterials for wound healing like skin substitutions, extracellular matrix proteins, and other therapeutic agents, among other treatment options, are providing impetus to the market growth. The robust research programmes implemented in developing wound care products are further expected to promote the adoption of advanced treatment options for bettering the healing process of diabetic ulcers in the coming years. Moreover, the strong market penetration of leading industry players, rising awareness about treatment options, and the flourishing healthcare sector around the world are also expected to have a positive influence on the growth of the market.

Key Industry Players in the Global Diabetic Ulcer Treatment Market

The report presents a detailed analysis of the following key players in the global diabetic ulcer treatment market, looking into their capacity, market share, and latest developments like capacity expansions, plant turnabouts and mergers and acquisitions:

• ConvaTec Group plc
• Acelity L.P. Inc.
• 3M Company
• Smith and Nephew Plc.
• B. Braun Melsungen Ag
• Medline Industries, LP,
• Medtronic Plc
• Organogenesis Holdings Inc
• Molnlycke Health Care AB
• BSN Medical GMBH
• Others

The comprehensive report looks at the micro and macro aspects of the industry. The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of the Porter’s Five Forces Model.

Key Highlights of the Report